Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Vitale

Showing results (251-260 of 288) with videos related to

Pageof 29
Sort By:
Journal of Hepatology|December 3, 2014
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre studyAlessandro Vitale, Patrizia Burra, Anna Chiara Frigo, et al.
Cancers|May 14, 2025
Development and Validation of a Pre-Transplant Risk Score (LT-MVI Score) to Predict Microvascular Invasion in Hepatocellular Carcinoma Candidates for Liver TransplantationQuirino Lai, Timothy M Pawlik, Suela Ajdini, et al.
Cancers|February 21, 2020
Identification of an Upper Limit of Tumor Burden for Downstaging in Candidates with Hepatocellular Cancer Waiting for Liver Transplantation: A West-East Collaborative EffortQuirino Lai, Alessandro Vitale, Karim Halazun, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2026
Early and late survival dynamics of immunotherapy combinations in advanced HCC: Anchored indirect comparison of atezolizumab plus bevacizumab versus durvalumab + tremelimumabAndrea Casadei-Gardini, Terry Cheuk-Fung Yip, Alessandro Vitale, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 27, 2023
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resectionFilippo Pelizzaro, Franco Trevisani, Vittorio Simeon, et al.
Frontiers in Oncology|February 17, 2022
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative TreatmentFilippo Pelizzaro, Selion Haxhi, Barbara Penzo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2024
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 6, 2020
Monofocal hepatocellular carcinoma: How much does size matter?Filippo Pelizzaro, Barbara Penzo, Giulia Peserico, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 28, 2019
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort studyAlessandro Vitale, Fabio Farinati, Timothy M Pawlik, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 21, 2018
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study GroupAlessandro Vitale, Quirino Lai, Fabio Farinati, et al.
Pageof 29

Showing results (251-260 of 288) with videos related to

Sort By:
Pageof 29
Journal of Hepatology|December 3, 2014
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre studyAlessandro Vitale, Patrizia Burra, Anna Chiara Frigo, et al.
Cancers|May 14, 2025
Development and Validation of a Pre-Transplant Risk Score (LT-MVI Score) to Predict Microvascular Invasion in Hepatocellular Carcinoma Candidates for Liver TransplantationQuirino Lai, Timothy M Pawlik, Suela Ajdini, et al.
Cancers|February 21, 2020
Identification of an Upper Limit of Tumor Burden for Downstaging in Candidates with Hepatocellular Cancer Waiting for Liver Transplantation: A West-East Collaborative EffortQuirino Lai, Alessandro Vitale, Karim Halazun, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2026
Early and late survival dynamics of immunotherapy combinations in advanced HCC: Anchored indirect comparison of atezolizumab plus bevacizumab versus durvalumab + tremelimumabAndrea Casadei-Gardini, Terry Cheuk-Fung Yip, Alessandro Vitale, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 27, 2023
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resectionFilippo Pelizzaro, Franco Trevisani, Vittorio Simeon, et al.
Frontiers in Oncology|February 17, 2022
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative TreatmentFilippo Pelizzaro, Selion Haxhi, Barbara Penzo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2024
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 6, 2020
Monofocal hepatocellular carcinoma: How much does size matter?Filippo Pelizzaro, Barbara Penzo, Giulia Peserico, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 28, 2019
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort studyAlessandro Vitale, Fabio Farinati, Timothy M Pawlik, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 21, 2018
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study GroupAlessandro Vitale, Quirino Lai, Fabio Farinati, et al.
Pageof 29